Literature DB >> 17391153

Adiponectin in health and disease.

Deborah K Oh1, Theodore Ciaraldi, Robert R Henry.   

Abstract

Adipose tissue is an active metabolic tissue that secretes multiple metabolically important proteins, known as adipokines. Adiponectin is an important adipokine because of its beneficial effects on glucose and lipid metabolism. Low levels of adiponectin are associated with disease states such as diabetes and cardiovascular disease. Direct administration of adiponectin has been shown to be beneficial in animal models of diabetes, obesity and atherosclerosis. Adiponectin levels in humans can be increased through indirect methods such as weight loss or treatment with thiazolidinediones. This article will review the epidemiology and therapeutic options with adiponectin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17391153     DOI: 10.1111/j.1463-1326.2006.00610.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  78 in total

1.  Adiponectin is associated with risk of the metabolic syndrome and insulin resistance in women.

Authors:  George A King; Sarah E Deemer; Dixie L Thompson
Journal:  Acta Diabetol       Date:  2010-05-08       Impact factor: 4.280

Review 2.  What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?

Authors:  Carmine Finelli; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

Review 3.  [Adipokines in healthy and obese children].

Authors:  G A Martos-Moreno; J J Kopchick; J Argente
Journal:  An Pediatr (Barc)       Date:  2012-11-24       Impact factor: 1.500

Review 4.  Novel metabolic biomarkers of cardiovascular disease.

Authors:  Majken K Jensen; Monica L Bertoia; Leah E Cahill; Isha Agarwal; Eric B Rimm; Kenneth J Mukamal
Journal:  Nat Rev Endocrinol       Date:  2014-09-02       Impact factor: 43.330

5.  Serum adiponectin and bone mineral density in male hemodialysis patients.

Authors:  S Okuno; E Ishimura; K Norimine; N Tsuboniwa; S Kagitani; K Yamakawa; T Yamakawa; K K Sato; T Hayashi; S Shoji; Y Nishizawa; M Inaba
Journal:  Osteoporos Int       Date:  2011-09-17       Impact factor: 4.507

Review 6.  New and emerging biomarkers in cardiovascular disease.

Authors:  Leah E Cahill; Monica L Bertoia; Sarah A Aroner; Kenneth J Mukamal; Majken K Jensen
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

Review 7.  Obesity: a review of pathogenesis and management strategies.

Authors:  Brinderjit Kaila; Maitreyi Raman
Journal:  Can J Gastroenterol       Date:  2008-01       Impact factor: 3.522

8.  Selective regulation of cellular and secreted multimeric adiponectin by antidiabetic therapies in humans.

Authors:  Susan A Phillips; Jacqueline Kung; Theodore P Ciaraldi; Charles Choe; Louis Christiansen; Sunder Mudaliar; Robert R Henry
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-07-21       Impact factor: 4.310

9.  Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women.

Authors:  Christin Heidemann; Qi Sun; Rob M van Dam; James B Meigs; Cuilin Zhang; Shelley S Tworoger; Christos S Mantzoros; Frank B Hu
Journal:  Ann Intern Med       Date:  2008-09-02       Impact factor: 25.391

Review 10.  Adipokines: Biomarkers for osteoarthritis?

Authors:  Thitiya Poonpet; Sittisak Honsawek
Journal:  World J Orthop       Date:  2014-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.